Lurata 80 Tablet contains Lurasidone 80 mg, an atypical antipsychotic indicated for the treatment of schizophrenia and bipolar depression. Lurasidone exerts its therapeutic effects primarily through antagonism of dopamine D2 and serotonin 5-HT2A receptors, contributing to the regulation of neurotransmitter activity in the central nervous system. This mechanism helps alleviate symptoms such as hallucinations, delusions, mood disturbances, and cognitive impairments associated with these psychiatric conditions. Lurata 80 is administered orally and should be taken exactly as prescribed by a healthcare professional. Dosage adjustments may be necessary based on clinical response and tolerability. Common adverse effects include nausea, somnolence, akathisia, and extrapyramidal symptoms, while serious side effects may involve metabolic changes, neuroleptic malignant syndrome, and tardive dyskinesia. Regular monitoring of metabolic parameters, neurological status, and overall mental health is recommended during treatment. Lurasidone is contraindicated in patients with known hypersensitivity to the drug and should be used cautiously in individuals with a history of seizures, cardiovascular disease, or hepatic impairment. Lurata 80 Tablet should be stored at room temperature, away from moisture and light, and kept out of reach of children. It is essential to consult a healthcare provider before initiating or discontinuing therapy.